Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.

@article{Pico1993ShouldVB,
  title={Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.},
  author={J. L. Pico and J. P. Marie and Dan Chiche and Marguerite Guiguet and Antoine Andremont and V{\'e}ronique Lapierre and Herv{\'e} M Richet and Cyrille Tancr{\`e}de and Philippe Henri Lagrange and Muhammad Hayat},
  journal={The European journal of medicine},
  year={1993},
  volume={2 5},
  pages={275-80}
}
OBJECTIVES We conducted a randomized trial with ceftazidine alone or associated with amikacin or vancomycin to investigate the efficacy of the daily 3 g dosage of ceftazidime and the efficacy of monotherapy with ceftazidime and to determine if vancomycin should be added empirically. METHODS Patient inclusion criteria were: age over 10 years, therapeutically-induced neutropenia and fever for at least three hours above 38.5 degrees C in absence of a clear non-infectious aetiology. Patients were… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
8 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…